FGMCR

Value Q4, 24Q1, 25Q2, 25Q3, 25 TTM Total revenue ———— — Gross profit ———— — Operating expenses 266126.86 K83.54 K592.59 K 803.25 K Selling/general/admin expenses 266126.86 K83.54 K592.59 K 803.25 K Research & development ———— — Operating income -266-126.86 K-83.54 K-592.59 K -803.25 K Non-Operating Income, Total —442.21 K960.05 K847.93 K — Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses —-117.55 K960.05 K847.93 K — Unusual income/expense —559.75 K—— — Pretax income -266315.35 K876.51 K255.33 K 1.45 M Equity in earnings ———— — Taxes 0117.55 K176.92 K178.06 K — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -265315.46 K582.14 K77.38 K 974.71 K Discontinued operations ———— — Net income -265315.46 K582.14 K77.38 K 974.71 K Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -265315.35 K582.03 K77.27 K 974.39 K Basic earnings per share (Basic EPS) -00.06-0.060.02 — Diluted earnings per share (Diluted EPS) -0-0.080.090.01 — Average basic shares outstanding 2.21 M7.65 M8.98 M9.42 M 28.27 M Diluted shares outstanding 2.21 M8.19 M9.67 M10.16 M 30.23 M EBITDA ———— — EBIT ———— — Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) ———— —